U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir

Gilead Science Inc's antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.

from Reuters: Top News https://ift.tt/35odRaF